Edwards Lifesciences Veteran Katie Szyman Named Next Masimo CEO. The Irvine-based medical device maker last week announced ...

BTIG analyst Marie Thibault reiterated a Buy rating on Masimo (MASI – Research Report) today and set a price target of $178.00. The company’s ...

A Delaware jury has ruled in favor of Apple Inc. (NASDAQ:AAPL) in a patent infringement case against Masimo Corp.

IRVINE, Calif., January 16, 2025--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ended December 28 ...

IRVINE, Calif., January 21, 2025--Today the Board of Directors (the "Board") of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie Szyman has been appointed the next ...

Today the Board of Directors (the "Board") of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie Szyman has been appointed the next Chief Executive Officer ("CEO") of the ...

Masimo expects to post revenue growth in its fourth-quarter, part of a snapshot into its financial performance provided with preliminary results and guidance. The medical technology company said ...

Masimo appointed Katie Szyman as its next chief executive officer after a proxy fight forced out the company's founder.